View Document Preview and Link Document Date: 2010-02-11 16:34:15 Open Document File Size: 63,61 KB Share Result on Facebook
Company Laboratory Tests Laboratory / Ames / / Currency pence / / Event Product Issues / Product Recall / FDA Phase / / IndustryTerm machinery / human hepatic enzyme systems / dangerous machinery / chemical name / treatment of panic disorder / extendedrelease products / Drug products / / MedicalCondition choking / chest pain / CNS Depression / congenital abnormalities / Seizures / panic attack / panic disorder / agoraphobia / nausea / open angle glaucoma / both alcoholic liver disease / induced seizure / numbness / dysosmia / diarrhea / muscle cramps / muscle twitch / illness / panic disorder taking / alcoholism / ataxia / single seizure / insomnia / disease / patients developing seizures / alcoholic liver disease / withdrawal seizures / shortness of breath / pulmonary function / recurrent unexpected panic attacks / Carcinogenesis / Mania / severe pulmonary disease / acute narrow angle glaucoma / primary and secondary major depressive disorders / seizure / withdrawal symptoms / depression / paresthesias / acute renal failure / status epilepticus / / MedicalTreatment Oral Contraceptives / antibiotics / hypnosis / / Organization Chronic administration / DOSAGE AND ADMINISTRATION / FDA / / Position physician / General / / Product itraconazole / symptoms / cyclosporine / XANAX / Reactions / carbamazepine / seizures / Each XANAX XR / clarithromycin / erythromycin / Cimetidine / nifedipine / isoniazid / diazepam / Fluoxetine / XANAX XR / ketoconazole / alprazolam / Dose Reduction / concentration / CYP3A / occupations / Performance Because of / / PublishedMedium Episodes / / Technology Pharmacokinetics / Pharmacodynamics / / SocialTag 
FDA APPROVED LABELING FOR XANAX XR Attachment to FDA Approval Letter for NDA[removed]